Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence

The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 compl...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Critical reviews in oncology/hematology Ročník 150; s. 102972
Hlavní autoři:	Moujaess, Elissar, Kourie, Hampig Raphael, Ghosn, Marwan
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier B.V 01.06.2020
Témata:	Adult Antineoplastic Agents - therapeutic use Betacoronavirus Cancer patients Clinical Laboratory Techniques Coronavirus Infections - complications Coronavirus Infections - diagnosis Coronavirus Infections - drug therapy Coronavirus Infections - therapy COVID-19 COVID-19 Drug Treatment COVID-19 Testing Humans Immunocompromised Host Neoplasms - complications Neoplasms - therapy Oncology Pandemics Pneumonia, Viral - complications Pneumonia, Viral - diagnosis Pneumonia, Viral - therapy SARS-CoV-2 Systematic review COVID-19 Systematic review Oncology Cancer patients Research
ISSN:	1040-8428, 1879-0461, 1879-0461
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!